Maxim Group Maintains Buy on American Bitcoin, Raises Price Target to $16
Maxim Group analyst Matthew Garland maintains American Bitcoin (NASDAQ:ABTC) with a Buy and raises the price target from $15 to $16.
Stocks · News reference
First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday
U.S. stocks mixed; First Tracks Biotherapeutics surged 18% on positive celiac trial results, while C3.ai, Liquidia and others also gained.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
HC Wainwright & Co. Assumes American Bitcoin at Buy, Announces Price Target of $22
HC Wainwright & Co. analyst Mike Colonnese assumes American Bitcoin (NASDAQ:ABTC) with a Buy rating and announces Price Target of $22.
Shares of crypto-linked companies are trading lower amid a drop in Bitcoin after rising yields, a stronger dollar and ongoing conflict in the Middle East cool risk appetite.
C3.ai vs. UiPath: Which AI-Driven Tech Stock Is a Better Buy in 2026?
The article compares C3.ai and UiPath as investments in the agentic AI automation space. UiPath is recommended as the better buy due to its profitability, positive free cash flow, and consistent growth trajectory. C3.ai, while showing recent improvements like positive free cash flow and 73% quarter-over-quarter booking growth, remains unprofitable with substantial net losses and is still in early restructuring stages under CEO Thomas Siebel.
'Trump Administration Plans to Move AI Testing Agency Officials to White House; The White House Seeks To Integrate Caissi Into AI Decision-making Process' - The Information
https://www.theinformation.com/articles/trump-administration-plans-move-ai-testing-agency-officials-white-house
Northland Capital Markets Upgrades C3.ai to Outperform, Raises Price Target to $16
Northland Capital Markets analyst Michael Latimore upgrades C3.ai (NYSE:AI) from Market Perform to Outperform and raises the price target from $10 to $16.